Roxybond - NDC Database

9 records found

Page:1

65597-501 Apr 20, 2017
Roxybond 5 mg Oral Tablet, Coated by Daiichi Sankyo Inc.

65597-502 Apr 20, 2017
Roxybond 15 mg Oral Tablet, Coated by Daiichi Sankyo Inc.

65597-503 Apr 20, 2017
Roxybond 30 mg Oral Tablet, Coated by Daiichi Sankyo Inc.

69296-005 Oct 01, 2017
Roxybond 5 mg Oral Tablet, Coated by Inspirion Delivery Sciences LLC

69296-006 Oct 01, 2017
Roxybond 15 mg Oral Tablet, Coated by Inspirion Delivery Sciences LLC

69296-007 Oct 01, 2017
Roxybond 30 mg Oral Tablet, Coated by Inspirion Delivery Sciences LLC

81140-101 Mar 31, 2022
Roxybond 5 mg Oral Tablet, Coated by Protega Pharmaceuticals LLC

81140-102 Mar 31, 2022
Roxybond 15 mg Oral Tablet, Coated by Protega Pharmaceuticals LLC

81140-103 Mar 31, 2022
Roxybond 30 mg Oral Tablet, Coated by Protega Pharmaceuticals LLC

Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.